Literature DB >> 1807815

Relation of giant cell arteritis to polymyalgia rheumatica.

L A Healey.   

Abstract

Polymyalgia rheumatica and temporal arteritis appear to be separate syndromes rather than two manifestations of an underlying giant cell arteritis. Polymyalgia rheumatica is a synovitis that may be persistent or recurrent, while temporal arteritis is almost always a single episode; documented recurrences are rare. The two syndromes frequently occur in the same patient although not necessarily at the same time and they may be separated by a long interval. In some patients with polymyalgia rheumatica, giant cell arteritis is found on biopsy of an asymptomatic temporal artery. The frequency of this concurrence is variable in different populations. It is high in Scandinavia, low in Israel and intermediate between these extremes in other populations that have been studied.

Entities:  

Mesh:

Year:  1991        PMID: 1807815     DOI: 10.1016/s0950-3579(05)80059-7

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  5 in total

Review 1.  Combination therapy in autoimmune disease: vasculitis.

Authors:  D Carruthers; P Bacon
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Spondyloarthropathy presenting as a polymyalgia rheumatica-like syndrome.

Authors:  A Ponce; R Sanmarti; C Orellana; J Muñoz-Gomez
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

3.  Polymyalgia rheumatica, temporal arteritis and malignancy.

Authors:  C A Speed; I Haslock
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

Review 4.  Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequences.

Authors:  Kosmas I Paraskevas; Dimitrios T Boumpas; George E Vrentzos; Dimitri P Mikhailidis
Journal:  Clin Rheumatol       Date:  2006-12-16       Impact factor: 3.650

Review 5.  Epidemiology and optimal management of polymyalgia rheumatica.

Authors:  P Labbe; P Hardouin
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.